Status:
COMPLETED
Clinical Investigation of Bleeding Reduction Efficacy on Toothpaste Containing 1.05% Chitosan
Lead Sponsor:
Colgate Palmolive
Conditions:
Bleeding Gum
Gingivitis
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The purpose of this study is to assess the bleeding reduction efficacy of toothpaste containing 1.05% Chitosan compared to a regular fluoride toothpaste, and compared to a toothpaste containing 67% bi...
Eligibility Criteria
Inclusion
- Male or female subjects, aged 18-70, inclusive.
- Availability for the duration of the study.
- Ability to understand and willingness to read, and sign the Informed Consent Form after the nature of the study has been fully explained to them.
- Willingness to comply with all study procedures and clinical examination schedules.
- Good general health (absence of any condition that, in the opinion of the study examiner, might constitute a risk to the subject while participating in the study. Examples include heart problems, valve/hip replacements etc).
- Presence of a minimum of 20 natural teeth (excluding third molars) with facial and lingual scoreable surfaces.
- Have a mean Modified Gingival Index (Lobene) ≥ 2.5 at screening.
- Subjects reporting bleeding while routine toothbrushing.
Exclusion
- Pregnant or lactating.
- Use of tobacco products.
- History of alcohol or drug abuse.
- Medical condition (especially, heart or liver problems, bleeding disorders, blood dyscrasias) or any current usage of medication that the investigator considers may compromise the subject safety, as well as, the quality of the study results.
- Medical condition which requires pre-medication prior to dental visits/procedures.
- History of allergy to oral hygiene products.
- Use of anti-inflammatory, immunosuppressive, antimicrobial or anticoagulant drugs or antibiotics in the 30 days prior to the start of the study and during the course of the study.
- Ongoing use of medications known to affect the gingival tissues (i.e. calcium channel blockers, phenytoin, cyclosporine).
- Presence of orthodontic bands or removable partial denture(s).
- Tumor (s) of the soft or hard tissues of the oral cavity.
- Five or more carious lesions requiring immediate restorative treatment.
- More than 2 periodontal pockets (\>4mm deep) with bleeding on probing.
- Any gingival condition like hyperplasia or overgrowth, that would cause difficulty in clinical assessment.
- Participation in any other clinical study with an oral care indication or test panel within 30 days prior to the start of the study.
- Existing medical condition which prohibits the subject from not eating or drinking for periods of up to 2 hours.
Key Trial Info
Start Date :
April 29 2025
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 4 2025
Estimated Enrollment :
134 Patients enrolled
Trial Details
Trial ID
NCT06955871
Start Date
April 29 2025
End Date
June 4 2025
Last Update
August 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
West China Dental Institute of Chengdu
Chengdu, Sichuan, China, 610041